{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T18:00:27Z","timestamp":1781719227743,"version":"3.54.5"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T00:00:00Z","timestamp":1627344000000},"content-version":"vor","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Research Foundation\u2014Flanders (FWO","award":["12I6319N"],"award-info":[{"award-number":["12I6319N"]}]},{"name":"University of Antwerp scientific chair in Evidence-Based Vaccinology"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GSK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Methusalem"},{"DOI":"10.13039\/501100011878","name":"Flemish Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011878","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Data on the consumption of macrolides, lincosamides and streptogramins (MLS) in the community were collected from 30 EU\/European Economic Area (EEA) countries over two decades. This article reviews temporal trends, seasonal variation, presence of change-points and changes in composition of the main subgroups of MLS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>For the period 1997\u20132017, data on consumption of MLS, i.e. ATC group J01F, in the community and aggregated at the level of the active substance, were collected using the WHO ATC\/DDD methodology (ATC\/DDD index 2019). Consumption was expressed in DDD per 1000 inhabitants per day and in packages per 1000 inhabitants per day. Consumption of MLS was analysed and presented as trends, seasonal variation, presence of change-points and compositional changes, using a classification based on mean plasma elimination half-life for macrolides.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In 2017, consumption of MLS in the community expressed in DDD per 1000 inhabitants per day varied by a factor of 13 between countries with the highest (Greece) and the lowest (Sweden) consumption. Consumption of MLS did not change significantly up to 2003, after which it significantly increased up to 2007. No significant change was observed after 2007. Consumption of MLS showed high seasonal variation. The proportional consumption of long-acting macrolides significantly increased over time compared with that of intermediate-acting macrolides, and proportional consumption of the latter increased compared with that of short-acting macrolides.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Consumption of MLS did not change significantly over time during 2007\u20132017, while the proportional consumption of long-acting macrolides increased. Seasonal variation remained high, which suggests that MLS are still prescribed inappropriately in many countries.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkab175","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T19:13:45Z","timestamp":1620846825000},"page":"ii30-ii36","source":"Crossref","is-referenced-by-count":26,"title":["Consumption of macrolides, lincosamides and streptogramins in the community, European Union\/European Economic Area, 1997\u20132017"],"prefix":"10.1093","volume":"76","author":[{"given":"Niels","family":"Adriaenssens","sequence":"first","affiliation":[{"name":"Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium"},{"name":"Centre for General Practice, Department of Family Medicine & Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4217-2869","authenticated-orcid":false,"given":"Robin","family":"Bruyndonckx","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium"},{"name":"Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Versporten","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niel","family":"Hens","sequence":"additional","affiliation":[{"name":"Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium"},{"name":"Centre for Health Economic Research and Modelling Infectious Diseases, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique L","family":"Monnet","sequence":"additional","affiliation":[{"name":"Disease Programmes Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Molenberghs","sequence":"additional","affiliation":[{"name":"Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium"},{"name":"Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Catholic University of Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Goossens","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Weist","sequence":"additional","affiliation":[{"name":"Disease Programmes Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1238-8052","authenticated-orcid":false,"given":"Samuel","family":"Coenen","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium"},{"name":"Centre for General Practice, Department of Family Medicine & Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the ESAC-Net study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhild","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline","family":"Vandael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefana","family":"Sabtcheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjana Tambi\u0107","family":"Andra\u0161evi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isavella","family":"Kyriakidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159\u00ed","family":"Vl\u010dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute Wolff","family":"S\u00f6nksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elviira","family":"Linask","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmi","family":"Sarvikivi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karima","family":"Hider-Mlynarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muna Abu","family":"Sin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Kontopidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ria","family":"Benk\u0151","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Aspelund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Oza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Fortinguerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ieva","family":"Rutkovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolanda","family":"Valint\u0117lien\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Bruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Zarb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Natsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege Salvesen","family":"Blix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Olczak-Pie\u0144kowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Adrian","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"Tesa\u0159","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"\u010ci\u017eman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayte Alonso","family":"Herreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vendela","family":"Bergfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berit","family":"M\u00fcller-Pebody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,1]]},"reference":[{"key":"2021090121422160400_dkab175-B1","year":"2020"},{"key":"2021090121422160400_dkab175-B2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/jac\/dkl184","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe","volume":"58","author":"Coenen","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"2021090121422160400_dkab175-B3","doi-asserted-by":"crossref","first-page":"vi37","DOI":"10.1093\/jac\/dkr190","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997\u20132009)","volume":"66","author":"Adriaenssens","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"2021090121422160400_dkab175-B4","first-page":"ii7\u2013ii13","article-title":"Consumption of antibiotics in the community, European Union\/European Economic Area, 1997\u20132017","volume":"76","author":"Bruyndonckx","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"2021090121422160400_dkab175-B5","first-page":"ii2\u2013ii6","article-title":"Consumption of antibiotics in the community, European Union\/European Economic Area, 1997\u20132017: data collection, management and analysis","volume":"76","author":"Bruyndonckx","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"2021090121422160400_dkab175-B6","first-page":"ii79\u2013ii85","article-title":"Analysing the trend over time of antibiotic consumption in the community: a tutorial on the detection of common change-points","volume":"76","author":"Bruyndonckx","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 6","key":"2021090121422160400_dkab175-B7","doi-asserted-by":"crossref","first-page":"vi89","DOI":"10.1093\/jac\/dkr461","article-title":"Analysing the composition of outpatient antibiotic use: a tutorial on compositional data analysis","volume":"66","author":"Faes","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2021090121422160400_dkab175-B8","year":"2020"},{"key":"2021090121422160400_dkab175-B9","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(07)60235-9","article-title":"Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study","volume":"369","author":"Malhotra-Kumar","year":"2007","journal-title":"Lancet"},{"key":"2021090121422160400_dkab175-B10","first-page":"1308","article-title":"US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011","volume":"60","author":"Hicks","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2021090121422160400_dkab175-B11","year":"2017"},{"key":"2021090121422160400_dkab175-B12","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/512810","article-title":"Comparison of outpatient systemic antibiotic use in 2004 between the United States and 27 European countries","volume":"44","author":"Goossens","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2021090121422160400_dkab175-B13","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03672.x","article-title":"Guidelines for the management of adult lower respiratory tract infections - full version","volume":"17","author":"Woodhead","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 2","key":"2021090121422160400_dkab175-B14","first-page":"ii14\u2013ii21","article-title":"Consumption of penicillins in the community, European Union\/European Economic Area, 1997\u20132017","volume":"76","author":"Bruyndonckx","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"2021090121422160400_dkab175-B15","first-page":"ii22\u2013ii29","article-title":"Consumption of cephalosporins in the community, European Union\/European Economic Area, 1997\u20132017","volume":"76","author":"Versporten","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"2021090121422160400_dkab175-B16","first-page":"ii45\u2013ii59","article-title":"Consumption of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in the community, European Union\/European Economic Area, 1997\u20132017","volume":"76","author":"Versporten","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"2021090121422160400_dkab175-B17","first-page":"ii37\u2013ii44","article-title":"Consumption of quinolones in the community, European Union\/European Economic Area, 1997\u20132017","volume":"76","author":"Adriaenssens","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"2021090121422160400_dkab175-B18","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3201\/eid1809.120049","article-title":"Antimicrobial drug use and macrolide-resistant Streptococcus pyogenes, Belgium","volume":"18","author":"Van Heirstraeten","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"2021090121422160400_dkab175-B19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/jac\/dkn432","article-title":"Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A)","volume":"63","author":"Malhotra-Kumar","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"2021090121422160400_dkab175-B20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","article-title":"Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption","volume":"62","author":"Megraud","year":"2013","journal-title":"Gut"},{"key":"2021090121422160400_dkab175-B21"},{"key":"2021090121422160400_dkab175-B22"},{"key":"2021090121422160400_dkab175-B23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10096-019-03490-6","article-title":"Adherence to antibiotic guidelines for erysipelas or cellulitis is associated with a favorable outcome","volume":"38","author":"Klotz","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2021090121422160400_dkab175-B24"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/76\/Supplement_2\/ii30\/40215694\/dkab175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/76\/Supplement_2\/ii30\/40215694\/dkab175.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:45:42Z","timestamp":1630532742000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/76\/Supplement_2\/ii30\/6328676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":24,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2021,8,1]]},"published-print":{"date-parts":[[2021,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkab175","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,7,1]]},"published":{"date-parts":[[2021,7,1]]}}}